Results 11 to 20 of about 763,557 (307)
Journal of Extracellular Biology, 2022 Detection of cell‐free circulating tumour DNA (ctDNA) and cancer‐specific extracellular vesicles (EVs) in patient blood have been widely explored as non‐invasive biomarkers for cancer detection and disease follow up.
Mercedes Tkach +7 more
doaj +1 more source
Biomarkers of Pediatric Brain Tumors [PDF]
Frontiers in Pediatrics, 2013 Background and Need for Novel Biomarkers: Brain tumors are the leading cause of death by solid tumors in children. Although improvements have been made in their radiological detection and treatment, our capacity to promptly diagnose pediatric brain tumors in their early stages remains limited. This contrasts several other cancers where serum biomarkers
Mark D Russell +3 more
openaire +4 more sources
Myocardial Dysfunction in an Animal Model of Cancer Cachexia [PDF]
, 2011 Aims Fatigue is a common occurrence in cancer patients regardless of tumor type or anti-tumor therapies and is an especially problematic symptom in persons with incurable tumor disease.
Crawford, Danielle +7 more
core +2 more sources
Cancer Control, 2009 Background Morphologic and histopathologic markers have been the backbone for the classification and prognostic assessment of melanoma. Availability of an increasing number of molecular markers, however, provides the potential for refining diagnostic and prognostic categories in this disease.
Selma, Ugurel +2 more
openaire +2 more sources
The importance of circulating tumor products as „liquid biopsies” in colorectal cancer [PDF]
, 2018 Liquid biopsies represent an array of plasma analysis tests that are studied to evaluate and identify circulating tumor products, especially circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA).
Calborean, Veronica +6 more
core +4 more sources
Translational progress on tumor biomarkers [PDF]
Thoracic Cancer, 2015 AbstractThere is an urgent need to apply basic research achievements to the clinic. In particular, mechanistic studies should be developed by bench researchers, depending upon clinical demands, in order to improve the survival and quality of life of cancer patients.
Guo, Hongwei +8 more
openaire +3 more sources
Focused ultrasound-enabled brain tumor liquid biopsy [PDF]
, 2018 Although blood-based liquid biopsies have emerged as a promising non-invasive method to detect biomarkers in various cancers, limited progress has been made for brain tumors.
Chen, Hong +10 more
core +3 more sources
Hopes on immunotherapy targeting B7-H3 in neuroblastoma
Translational Oncology, 2023 Neuroblastoma is one of the most aggressive cancer forms in children, with highly heterogenous clinical manifestations ranging from spontaneous regression to high metastatic capacity.
Rafael Pulido, Caroline E. Nunes-Xavier
doaj +1 more source
Zyxin expression levels in non-small cell lung cancer patients [PDF]
Vojnosanitetski Pregled, 2020 Background/Aim. Non-small cell lung cancer (NSCLC) is the most common cause of cancer-related mortality worldwide. Early detection represents one of the most promising approaches to reduce lung cancer mortality.
Ilić Dejan +4 more
doaj +1 more source
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma [PDF]
, 2015 Accurate assessment of neuroblastoma outcome prediction remains challenging. Therefore, this study aims at establishing novel prognostic tumor DNA methylation biomarkers.
+24 more
core +2 more sources